Mobile Health Program for Teens With Congenital Heart Disease
Launched by KRISTEN FOX · Jul 3, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new mobile health program designed especially for teenagers who have congenital heart disease, which means they were born with a heart condition. The study wants to find out what teens think about the program—whether they like it, find it easy to use, and if it helps them learn more about their health and make healthier choices.
Teens between the ages of 12 and 18 who have a diagnosed heart condition from birth can take part in this study. To join, they need to be able to complete surveys and interviews in English and plan to stay in the United States during the study. Participants will be asked to fill out two online surveys, try out the mobile health program, and then take part in a short interview to share their thoughts. This study isn’t recruiting just yet, but it aims to make a helpful tool that supports teens in managing their heart health in a way that fits their needs and lifestyle.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of structural congenital heart disease
- • 12-18 years of age at time of study enrollment
- Exclusion Criteria:
- • Cognitive impairments limiting the ability to complete surveys or interviews
- • Not proficient in the English language
- • Leaving the United States during the study period
About Kristen Fox
Kristen Fox is a clinical trial sponsor dedicated to advancing medical research through the support and coordination of innovative clinical studies. With a focus on ensuring ethical standards and regulatory compliance, Kristen Fox plays a pivotal role in facilitating the development of new therapies and improving patient outcomes. Committed to fostering collaboration among researchers, healthcare professionals, and participants, Kristen Fox contributes to the progression of evidence-based medicine and the delivery of safe, effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported